Cyon Therapeutics Inc.(Cyon) announced that it has entered into a license agreement with Novartis AG (NYSE: NVS) for their anti-PCSK9 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE